Objective
The burden of rheumatic heart disease continues to be a major contributor morbidity and premature death in a poor and developing countries. In rheumatic heart disease, the mitral valve is involved in nearly all cases. At present, no medical therapy is known to affect the progression of rheumatic heart disease. Mitral stenosis can be caused by calcification which characterized by calcium by lipid deposition in the anular fibrosa of the mitral valve. Therefore, we aim to see the effect of statin treatment on progression of mitral stenosis in patients with rheumatic heart disease.
Methods
The data achieved by history taking, physical examination, and laboratory exam by physician when patient admitted to RSUD Mataram. Also, a structured Pubmed, Proquest and Cochrane search was conducted to get the evidence-based. After screening 140 articles on titles and abstract by applying exclusion and inclusion criteria, one article was considered useful by the author and only one was appraised concerning validity, importance and applicability as full texts.
Methods
The data achieved by history taking, physical examination, and laboratory exam by physician when patient admitted to RSUD Mataram. Also, a structured Pubmed, Proquest and Cochrane search was conducted to get the evidence-based. After screening 140 articles on titles and abstract by applying exclusion and inclusion criteria, one article was considered useful by the author and only one was appraised concerning validity, importance and applicability as full texts.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
